These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7205248)

  • 1. Effect of sleep deprivation on dopamine receptor function in normal subjects.
    Lal S; Thavundayil J; Nair NP; Etienne P; Rastogi R; Schwartz G; Pulman J; Guyda H
    J Neural Transm; 1981; 50(1):39-45. PubMed ID: 7205248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
    Lal S; Nair NP; Thavundayil JX; Tawar V; Quirion R; Guyda H
    J Neural Transm Gen Sect; 1991; 85(2):157-64. PubMed ID: 1930878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
    Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
    Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of apomorphine hydrochloride administration on serum concentrations of prolactin and growth hormone in cattle.
    Gorewit RC
    Experientia; 1981 Feb; 37(2):204-6. PubMed ID: 7238762
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
    Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
    Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REM sleep deprivation induces subsensitivity of dopamine receptors mediating sedation in rats.
    Serra G; Melis MR; Argiolas A; Fadda F; Gessa GL
    Eur J Pharmacol; 1981 Jun; 72(1):131-5. PubMed ID: 7262191
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men.
    Lal S; Nair NP; Iskandar HL; Etienne P; Wood PL; Schwartz G; Guyda H
    J Neural Transm; 1982; 54(1-2):75-84. PubMed ID: 7108512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
    Lal S; Nair NP; Eugenio H; Thavundayil J; Lizondo E; Wood PL; Etienne P; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):537-44. PubMed ID: 6320299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
    Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
    Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of L-tryptophan on apomorphine-induced growth hormone secretion in normal subjects.
    Lal S; Young SN; Cervantes P; Guyda H
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):331-5. PubMed ID: 7208604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased responsiveness to apomorphine after REM sleep deprivation: supersensitivity of dopamine receptors or increase in dopamine turnover?
    Tufik S
    J Pharm Pharmacol; 1981 Nov; 33(11):732-8. PubMed ID: 6118415
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of dopamine agonists in tardive dyskinesia.
    Smith RC; Tamminga CA; Haraszti J; Pandey GN; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):763-8. PubMed ID: 869053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man.
    Nair NP; Lal S; Thavundayil JX; Wood PL; Etienne P; Guyda H
    Neuropeptides; 1984 Jun; 4(4):281-91. PubMed ID: 6472582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of apomorphine on melatonin secretion in normal subjects.
    Lal S; Isaac I; Pilapil C; Nair NP; Hariharasubramanian N; Guyda H; Quirion R
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):229-33. PubMed ID: 3628830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain?
    Tufik S; Lindsey CJ; Carlini EA
    Pharmacology; 1978; 16(2):98-105. PubMed ID: 201949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
    Levy MI; Davis BM; Mohs RC; Kendler KS; Mathé AA; Trigos G; Horvath TB; Davis KL
    Arch Gen Psychiatry; 1984 May; 41(5):520-4. PubMed ID: 6372737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of central dopamine receptors in schizophrenia.
    Zemlan FP; Hitzemann RJ; Hirschowitz J; Garver DL
    Am J Psychiatry; 1985 Nov; 142(11):1334-7. PubMed ID: 2865903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuroendocrine study of supersensitivity in tardive dyskinesia.
    Tamminga CA; Smith RC; Pandey G; Frohman LA; Davis JM
    Arch Gen Psychiatry; 1977 Oct; 34(10):1199-203. PubMed ID: 911219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.